In a report released today, Bobby Griffin from Raymond James reiterated a Buy rating on Purple Innovation (PRPL). The company’s shares closed last Tuesday at $20.75.
According to TipRanks.com, Griffin is a 5-star analyst with an average return of 22.7% and a 70.2% success rate. Griffin covers the Consumer Goods sector, focusing on stocks such as Alimentation Couche Tard, Bed Bath & Beyond, and Leggett & Platt.
Currently, the analyst consensus on Purple Innovation is a Strong Buy with an average price target of $27.00, a 28.1% upside from current levels. In a report issued on August 7, Wedbush also maintained a Buy rating on the stock with a $27.00 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $27.75 and a one-year low of $4.42. Currently, Purple Innovation has an average volume of 1.07M.
Based on the recent corporate insider activity of 18 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PRPL in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Purple Innovation, Inc. engages in the design and manufacture of mattresses, cushions, pillows, and other comfort products. The firm uses Hyper-Elastic Polymer technology. Its products include mattresses, new purple mattress, original purple mattress, bed pillows, seat cushions, mattress protector, and bamboo sheets. The company was founded by Terry V. Pearce and Tony M. Pearce in 2010 and is headquartered in Alpine, Utah.
